Non-Current Assets
Total Assets
Vertex Pharmaceuticals Total Assets increased by 3.3% to $26.48B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.8%, from $22.88B to $26.48B. Over 5 years (FY 2020 to FY 2025), Total Assets shows an upward trend with a 16.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 5, 2026
How to read this metric
Growth in total assets generally signals business expansion, while a decline may indicate asset divestiture or significant impairment.
Detailed definition
This is the sum of all current and non-current assets owned by the company, representing the total economic resources av...
Peer comparison
Biotech companies with large drug portfolios typically maintain high asset bases due to capitalized R&D and intellectual property.
Metric ID:
total_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $12.22B | $12.62B | $13.43B | $14.26B | $15.58B | $16.71B | $18.15B | $18.97B | $20.35B | $21.73B | $22.73B | $23.92B | $20.13B | $22.24B | $22.53B | $22.88B | $24.04B | $24.86B | $25.64B | $26.48B |
| QoQ Change | — | +3.2% | +6.4% | +6.1% | +9.3% | +7.2% | +8.6% | +4.5% | +7.2% | +6.8% | +4.6% | +5.2% | -15.8% | +10.5% | +1.3% | +1.5% | +5.1% | +3.4% | +3.1% | +3.3% |
| YoY Change | — | — | — | — | +27.5% | +32.4% | +35.1% | +33.1% | +30.6% | +30.0% | +25.2% | +26.1% | -1.1% | +2.4% | -0.9% | -4.3% | +19.4% | +11.8% | +13.8% | +15.8% |
Range$12.22B – $26.48B
CAGR+17.7%
Avg YoY Growth+18.6%
Median YoY Growth+22.3%
Current Streak7 quarters growth
Total Assets at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's total assets?
- Vertex Pharmaceuticals (VRTX) reported total assets of $26.48B in Q1 2026.
- How has Vertex Pharmaceuticals's total assets changed year-over-year?
- Vertex Pharmaceuticals's total assets increased by 15.8% year-over-year, from $22.88B to $26.48B.
- What is the long-term trend for Vertex Pharmaceuticals's total assets?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's total assets has grown at a 16.9% compound annual growth rate (CAGR), from $11.75B to $25.64B.
- What does total assets mean?
- The combined value of everything the company owns, including cash, inventory, and long-term investments.